tiprankstipranks
Revive Therapeutics Ltd (TSE:RVV)
:RVV
Canadian Market
RVV
Revive Therapeutics
RESEARCH TOOLSreports

Revive Therapeutics (RVV) Stock News & Sentiment

132 Followers
Revive Extends Bucillamine Patent Shield Across Nerve-Agent and Infectious Disease Uses
Premium
Company Announcements
Revive Extends Bucillamine Patent Shield Across Nerve-Agent and Infectious Disease Uses
1M ago
Revive Therapeutics Updates on Nerve Agent Countermeasure Study
Premium
Company Announcements
Revive Therapeutics Updates on Nerve Agent Countermeasure Study
4M ago
Revive Therapeutics Updates on Nerve Agent Countermeasure Study
Premium
Company Announcements
Revive Therapeutics Updates on Nerve Agent Countermeasure Study
5M ago
Revive Therapeutics Closes Second Tranche of Private Placement
Premium
Company Announcements
Revive Therapeutics Closes Second Tranche of Private Placement
7M ago
Revive Therapeutics Extends Private Placement to Support Therapeutic Programs
Premium
Company Announcements
Revive Therapeutics Extends Private Placement to Support Therapeutic Programs
7M ago
Revive Therapeutics Completes First Tranche of Private Placement and Debt Settlement
Premium
Company Announcements
Revive Therapeutics Completes First Tranche of Private Placement and Debt Settlement
8M ago
Revive Therapeutics Announces Private Placement and Debt Settlement Plan
Premium
Company Announcements
Revive Therapeutics Announces Private Placement and Debt Settlement Plan
9M ago
More TSE:RVV News >

RVV News on the Web

Revive Extends Bucillamine Patent Shield Across Nerve-Agent and Infectious Disease Uses
TipRanks News
Neutral
Revive Therapeutics announces North American patent filings for bucillamine
TipRanks News
Bullish
Revive Therapeutics Updates on Nerve Agent Countermeasure Study
TipRanks News
Neutral
Revive Therapeutics Closes Second Tranche of Private Placement
TipRanks News
Neutral
Revive Therapeutics Extends Private Placement to Support Therapeutic Programs
TipRanks News
Neutral
Revive Therapeutics Advances Bucillamine Research for Nerve Agent Exposure
TipRanks News
Neutral
Revive Therapeutics (RVVTF) Proposes Debt Settlement via Share Issuance
GuruFocus News
Neutral
Revive Therapeutics Explores Bucillamine for Nerve Agents and Viral Threats
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:RVV’s Media Buzz Sentiment?
Currently, no data Available
What is TSE:RVV’s weekly average amount of articles?
Currently, no data Available
What is TSE:RVV’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week